Atul Pande insider trades: Immunovant (IMVT) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Atul reports to the SEC
Open-market buys and sales
33 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 28, 2026 | IMVT | ↓ Sell | 1,500 | $43.27 | $65K | Direct | Aug 28, 2026 (0d) |
| Jul 24, 2026 | IMVT | ↓ Sell | 1,500 | $39.80 | $60K | Direct | Jul 24, 2026 (0d) |
| Jun 26, 2026 | IMVT | ↓ Sell | 1,500 | $38.01 | $57K | Direct | Jun 26, 2026 (0d) |
| Jun 15, 2026 | IMVT | ↓ Sell | 1,500 | $34.02 | $51K | Direct | Jun 16, 2026 (1d) |
| May 20, 2026 | IMVT | ↓ Sell | 6,000 | $32.00 | $192K | Direct | May 20, 2026 (0d) |
| Dec 2, 2024 | IMVT | ↓ Sell10b5-1 | 7,750 | $28.54 | $221K | Direct | Dec 4, 2024 (2d) |
| Dec 1, 2023 | IMVT | ↓ Sell | 12,350 | $39.73 | $491K | Direct | Dec 5, 2023 (4d) |
| Sep 30, 2022 | IMVT | ↑ Buy | 15,000 | $5.60 | $84K | By Trust | Oct 4, 2022 (4d) |
| Feb 1, 2022 | KRTX | ↓ Sell | 2,500 | $110.80 | $277K | Direct | Feb 2, 2022 (1d) |
| Jan 3, 2022 | KRTX | ↓ Sell | 2,500 | $130.44 | $326K | Direct | Jan 3, 2022 (0d) |
| Dec 1, 2021 | KRTX | ↓ Sell | 2,500 | $127.73 | $319K | Direct | Dec 2, 2021 (1d) |
| Nov 1, 2021 | KRTX | ↓ Sell | 2,500 | $136.67 | $342K | Direct | Nov 3, 2021 (2d) |
| Oct 1, 2021 | KRTX | ↓ Sell | 2,500 | $120.72 | $302K | Direct | Oct 1, 2021 (0d) |
| Sep 1, 2021 | KRTX | ↓ Sell | 2,500 | $117.82 | $295K | Direct | Sep 1, 2021 (0d) |
| Aug 13, 2021 | IMVT | ↑ Buy | 5,000 | $7.98 | $40K | Purchased through Trust Owned by Atul Pa | Aug 16, 2021 (3d) |
| Aug 2, 2021 | KRTX | ↓ Sell | 2,500 | $114.17 | $285K | Direct | Aug 2, 2021 (0d) |
| Jul 1, 2021 | KRTX | ↓ Sell | 2,500 | $112.66 | $282K | Direct | Jul 1, 2021 (0d) |
| Jun 1, 2021 | KRTX | ↓ Sell | 2,500 | $111.44 | $279K | Direct | Jun 1, 2021 (0d) |
| May 3, 2021 | KRTX | ↓ Sell | 5,000 | $115.31 | $577K | Direct | May 3, 2021 (0d) |
| Mar 1, 2021 | KRTX | ↓ Sell | 2,500 | $125.43 | $314K | Direct | Mar 3, 2021 (2d) |
| Feb 1, 2021 | KRTX | ↓ Sell | 2,500 | $100.00 | $250K | Direct | Feb 1, 2021 (0d) |
| Dec 14, 2020 | KRTX | ↓ Sell | 5,714 | $92.64 | $529K | Direct | Dec 14, 2020 (0d) |
| Nov 24, 2020 | SIOX | ↑ Buy | 10,000 | $2.34 | $23K | By Atul C. Pande and Patricia A Pande TR | Nov 25, 2020 (1d) |
| Nov 12, 2020 | KRTX | ↓ Sell | 5,000 | $96.84 | $484K | Direct | Nov 12, 2020 (0d) |
| Nov 3, 2020 | KRTX | ↓ Sell | 5,000 | $85.00 | $425K | Direct | Nov 3, 2020 (0d) |
| Sep 16, 2020 | KRTX | ↓ Sell | 5,000 | $85.00 | $425K | Direct | Sep 18, 2020 (2d) |
| Aug 12, 2020 | KRTX | ↓ Sell | 5,000 | $85.00 | $425K | Direct | Aug 14, 2020 (2d) |
| Aug 12, 2020 | KRTX | ↓ Sell | 5,000 | $85.00 | $425K | Direct | Aug 14, 2020 (2d) |
| Jul 13, 2020 | KRTX | ↓ Sell | 5,000 | $95.43 | $477K | Direct | Jul 13, 2020 (0d) |
| Jul 8, 2020 | AXGT | ↑ Buy | 10,000 | $2.73 | $27K | By Atul C. Pande & Patricia A Pande TR D | Jul 10, 2020 (2d) |
| Jun 12, 2020 | KRTX | ↓ Sell | 5,000 | $93.27 | $466K | Direct | Jun 15, 2020 (3d) |
| Mar 16, 2020 | AXGT | ↑ Buy | 10,000 | $1.78 | $18K | By Atul C. Pande & Patricia A Pande TR D | Mar 18, 2020 (2d) |
| Jun 14, 2019 | AXGT | ↑ Buy | 3,370 | $5.22 | $18K | Direct | Jun 17, 2019 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other IMVT insiders
Open-market trades in the last 12 months
About Atul Pande's insider trades
Atul Pande is a director at Immunovant (IMVT). Since Jun 14, 2019, Atul has reported 6 open-market purchases worth $210K and 27 sales worth $8.6M on SEC Form 4. In the last 12 months: 5 sales ($425K).
1 sale (3% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include option exercises (25 filings), grants and awards (20 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IMVT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.